Argenx, NL0010832176

Argenx stock last at EUR 842.40, up 0.91 percent in Euronext trading

Published on 09/25/2026 at 18:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Argenx stock was last at EUR 842.40 in Euronext Brussels trading at 5:12 p.m. CEST, up 0.91 percent from the previous close. The US-listed shares were at USD 958.15 in trading at 12:20 p.m. ET.

Fotorealistisches Laborpanorama: Wissenschaftler in weißen Kitteln begutachten leuchtende Antikörper-3D-Modelle auf Bildschirmen, Stahltische mit Laborgeräten im Hintergrund
Argenx NL0010832176 Forscher analysieren im modernen Biopharma-Labor leuchtende Antikörper-Strukturen auf großen Monitoren, Illustration mit AI erstellt.

Argenx was last at EUR 842.40 in Euronext Brussels trading at 5:12 p.m. CEST on September 25, 2026, up EUR 7.60 or 0.91 percent. The move placed the shares EUR 82.60 below the reported 52-week high of EUR 925.00. The US-listed shares were at USD 958.15 in New York trading at 12:20 p.m. ET, down USD 4.07 or 0.42 percent.

Argenx trading on September 25, 2026

Argenx SE (ISIN NL0010832176) was last quoted at EUR 842.40 on the Brussels listing at 5:12 p.m. CEST. The prior Brussels price was EUR 834.80, giving the session a gain of EUR 7.60. The session record also placed the stock below its 52-week high of EUR 925.00. The latest US quote was USD 958.15 at 12:20 p.m. ET.

Argenx shares were up 0.91 percent in Brussels while the US line was down 0.42 percent. The difference between the two quoted moves was 1.33 percentage points. The US quote carried a day range from USD 956.88 to USD 967.54. The US session value was recorded before the regular New York session ended.

Board appointments remain the latest company-specific focus

Argenx shares had recently drawn attention after shareholders approved Thomas M. Brakel and Khurem Farooq as non-executive directors. As Yahoo Finance reported on September 24, 2026, the appointments prompted renewed discussion of the boards longer-term direction. The report placed the shares at EUR 835.80 before the latest Brussels indication.

Recent company attention has also centered on argenxs autoimmune pipeline and the commercial reach of its lead franchise. The September 25 Brussels indication was EUR 6.60 above the EUR 835.80 level cited in the prior-day report. The move represented a 0.79 percent increase from that cited level. The US quote moved in the opposite direction at the stated time.

Brussels listing and New York trading on September 25, 2026

Euronext Brussels trading showed EUR 842.40 for Argenx at 5:12 p.m. CEST, while the US listing showed USD 958.15 at 12:20 p.m. ET. The Brussels move was positive at 0.91 percent, compared with a 0.42 percent decline in New York trading. The US session volume was 109,505.25 shares at the recorded time. The two listings therefore showed a 1.33 percentage-point gap in reported daily performance.

Disclaimer...

en | NL0010832176 | ARGENX | boerse | 70184701 | bgmi